Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01924936 · ClinicalTrials.gov registry record · NA

Now Matters Now: An Online Suicide Prevention Program

A NA study of Suicide and Suicidal Ideation, sponsored by Kaiser Permanente.

Completed
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT01924936 is a NA study of Suicide and Suicidal Ideation that has completed, run by Kaiser Permanente. The registered enrollment target is 200 participants, below the 6,988-participant average among 92 other Suicide trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01924936, a NA study of Suicide and Suicidal Ideation, has completed, sponsored by Kaiser Permanente.

COMPLETED
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

In the United States in 2010, 38,000 people died from suicide and it is our nation's 10 leading cause of death. Suicide prevention is a national priority and yet secondary prevention programs targeting those most at risk are lacking. The purpose of the current research is to develop and pilot test three promising suicide prevention programs that, if found acceptable to high-risk individuals, could be further evaluated and eventually offered broadly and affordably to the public.

Interventions

  • BEHAVIORAL DBT Online Program

Study Locations (1)

Washington

  • Group Health Research Institute - Seattle

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2012-07
Est. Completion 2014-12
Phase NA

Sponsor

Kaiser Permanente

294 total trials

What the Registry Record Tells You About NCT01924936

The ClinicalTrials.gov registry entry for NCT01924936 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,988-participant average among 92 other Suicide trials with a reported enrollment target (97% lower). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Suicide appearing as the primary indexed condition, and to 1 intervention - of which DBT Online Program is the first listed.

NCT01924936 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT01924936 about?

NCT01924936 is a clinical study titled "Now Matters Now: An Online Suicide Prevention Program". In the United States in 2010, 38,000 people died from suicide and it is our nation's 10 leading cause of death. Suicide prevention is a national priority and yet secondary prevention programs targeting those most at risk are lacking. The purpose of the current research is to develop and pilot test t...

What is the current status of trial NCT01924936?

This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2012-07. Estimated completion is 2014-12.

What conditions does trial NCT01924936 study?

This clinical trial studies the following conditions: Suicide, Suicidal Ideation, Suicide, Attempted.

What interventions are being tested in trial NCT01924936?

The interventions under investigation include: DBT Online Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT01924936?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01924936 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicide

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.